EBR Systems
EBR Systems Inc. is a medical device company specializing in innovative solutions for cardiac rhythm management, focusing on leadless pacing technology. Their WiSE System offers a unique, physiologic approach to treating heart failure, setting them apart in the healthcare equipment sector.
Short position
EBR Systems (ASX:EBR) has 0.27% of its shares on issue reported as short positions as of 5 Oct 2026, or about 2,263,673 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has risen 0.13 percentage points. Its highest recorded short interest was 0.53% in September 2024. EBR is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4EBR Systems (EBR) financials
Results, ratios and statements
Latest result
12 months to 30 Jun 2026 (TTM Jun 26) vs TTM Jun 25, figures in USD, the reporting currency
- Revenue
- 6.4Mvs n/a (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- −60.8Mvs n/a (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- −0.18vs −0.12 (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- n/aFY
- EPS YoY
- n/aTTM
Key ratios
12 months to 30 Jun 2026 (TTM); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 14.5%
- Operating margin
- −895.8%
- Net margin
- −942.6%
- FCF margin
- −1,155.3%
- ROE
- −102.5%
- ROA
- −47.9%
- FCF conversion
- n/a
- Net cash (excl. leases)
- USD 18.2M
- Net debt / EBITDA
- n/a
- Current ratio
- 2.1×
- Interest cover
- −10.6×
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (listed unit is not one ordinary share)
- P/E
- n/a (listed unit is not one ordinary share)
- P/B
- n/a (listed unit is not one ordinary share)
Ratios use the reporting currency (USD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in USD, the reporting currency; Yahoo Finance unless marked
| Line item | TTM Jun 26 | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|---|
| Revenue | 6.4M | 1.6M | 0 | 0M (source: ASX (Markit)) | 0M (source: ASX (Markit)) |
| Gross profit | 932.0K | 490.0K | 0 | n/a | n/a |
| Operating income | −57.7M | −46.1M | −38.3M | n/a | n/a |
| EBITDA | −54.7M | −42.7M | −34.2M | n/a | n/a |
| EBIT | −55.3M | −43.1M | −34.8M | n/a | n/a |
| Interest expense | 5.5M | 5.6M | 6.0M | n/a | n/a |
| Pretax income | −60.8M | −48.8M | −40.8M | n/a | n/a |
| Tax | 2.0K | 2.0K | 2.0K | n/a | n/a |
| NPAT | −60.8M | −48.8M | −40.8M | −35.0MM (source: ASX (Markit)) | −33.1MM (source: ASX (Markit)) |
| Net interest income | −3.3M | −2.9M | −2.8M | n/a | n/a |
| EPS basic | −0.18 | −0.11 | −0.12 | −0.11 | −0.11 |
| EPS diluted | −0.18 | −0.11 | −0.12 | −0.11 | −0.11 |
| Shares | n/a | 45.0M | 37.1M | 309.4M | 291.4M |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- Correction of Annual ReportAnnual Report31 Mar 2026via asx_announcements
- Annual ReportAnnual Report27 Mar 2026via asx_announcements
- Quarterly Cash Flow ReportQuarterly Report19 Mar 2026via asx_announcements
- Annual ReportAnnual Report14 Apr 2025via asx_announcements
- Appendix 4E SEC Form 10KAnnual Results25 Mar 2025via asx_announcements
- Quarterly Cash Flow ReportQuarterly Report25 Mar 2025via asx_announcements
- Notice of Date for Q3 2024 Quarterly Report and Form 10-QQuarterly Report25 Oct 2024via asx_announcements
- Appendix 4D and Half Year Report & AccountsHalf Year Results27 Aug 2024via asx_announcements
- EBR Half Year Results 2024 and Securityholder UpdateHalf Year Results27 Aug 2024via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report26 Jul 2024via asx_announcements
Showing 10 of 49 reports